esculentin steroid

do not confuse with esculentin (antimicrobial peptide)

Also Known As:

esculentin; Pregn-5-en-20-one, 3-((O-6-deoxy-3-O-methyl-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-arabino-hexopyranosyl)oxy)-8,11,12,14,17-pentahydroxy-, (3beta,11alpha,12beta,14beta,17alpha)-

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Conlon, J Michael: 3 articles (10/2017 - 01/2013)
2.	Mangoni, Maria Luisa: 3 articles (02/2015 - 09/2009)
3.	Abdel-Wahab, Yasser H A: 2 articles (10/2017 - 01/2015)
4.	Flatt, Peter R: 2 articles (10/2017 - 01/2015)
5.	Ojo, Opeolu O: 2 articles (10/2017 - 01/2015)
6.	Vasu, Srividya: 2 articles (10/2017 - 01/2015)
7.	Luca, Vincenzo: 2 articles (02/2015 - 07/2014)
8.	Moffett, R Charlotte: 1 article (10/2017)
9.	Baidouri, Hasna: 1 article (02/2015)
10.	Kolar, Satya Sree N: 1 article (02/2015)

Related Diseases

1.	Infections 07/01/2014 - "Anti-Candida activity of 1-18 fragment of the frog skin peptide esculentin-1b: in vitro and in vivo studies in a Caenorhabditis elegans infection model."
2.	Insulin Resistance 10/01/2017 - "Actions of esculentin-2CHa(1-30) (GFSSIFRGVAKFASKGLGKDLAKLGVDLVA) and its analogues, ([D-Arg7, D-Lys15, D-Lys23]-esculentin-2CHa(1-30) and [Lys15-octanoate]-esculentin-2CHa(1-30), were evaluated in high-fat fed NIH Swiss mice with impaired glucose tolerance and insulin resistance. " 01/01/2015 - "Acute administration of [L28K]esculentin-2CHa (75 nmol/kg body weight) to high fat fed mice with obesity and insulin resistance enhanced glucose tolerance and insulin secretion. "
3.	Body Weight (Weight, Body) 01/01/2015 - "Twice-daily administration of this dose of [L28K]esculentin-2CHa for 28 days had no significant effect on body weight, food intake, indirect calorimetry or body composition. " 10/01/2017 - "administration of the esculentin-2CHa(1-30) peptides (75 nmol/kg body weight) or exendin-4 (25 nmol/kg) for 28 days reduced body weight, without altering cumulative energy intake. " 01/01/2015 - "Acute administration of [L28K]esculentin-2CHa (75 nmol/kg body weight) to high fat fed mice with obesity and insulin resistance enhanced glucose tolerance and insulin secretion. "
4.	Glucose Intolerance 10/01/2017 - "Actions of esculentin-2CHa(1-30) (GFSSIFRGVAKFASKGLGKDLAKLGVDLVA) and its analogues, ([D-Arg7, D-Lys15, D-Lys23]-esculentin-2CHa(1-30) and [Lys15-octanoate]-esculentin-2CHa(1-30), were evaluated in high-fat fed NIH Swiss mice with impaired glucose tolerance and insulin resistance. "
5.	Weight Loss (Weight Reduction) 10/01/2017 - "These data indicate that esculentin-2CHa(1-30) and its analogues may be useful for improvement of blood glucose control and weight loss in type 2 diabetes."

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Antimicrobial Cationic Peptides
3.	Glucose (Dextrose)
4.	Antimicrobial Peptides
5.	Exenatide (Byetta)
6.	octanoic acid (caprylic acid)

Related Therapies and Procedures

1.	Glycemic Control